Komal Gurnani

Bio:

ROLE : Komal is a Principal in ZS’s Strategy & Transformation practice focused on global pipeline planning and launch acceleration for biopharmaceutical clients. She leads ZS’s Global Launch Team and brings deep experience across portfolio and disease-area strategy, R&D strategy and program planning, MoA/platform prioritization, and launch execution—particularly through digital- and AI-enabled go-to-market models.

EXPERTISE: Komal’s deep experience and thought leadership across marketing advisory, launch planning, portfolio and brand planning is backed by depth in data and analytics. She excels at cross-functional team alignment on strategic solutions across pipeline planning, R&D, medical, market access, commercial topics. Since joining ZS in 2011, she has supported 40+ clients across Immunology, Cardiology, Respiratory, Diabetes/Metabolics, Renal-Hepatic, and Oncology.

EDUCATION: Harvard Medical School – Global Health Care Leaders Executive Program, Indian School of Business – MBA in Strategy & Marketing and Bachelor in Computer Science & Engineering (Hons)